Embarcadero Technologies, Inc. Announces Receipt of Extension of NASDAQ Deadline
April 24 2007 - 9:00AM
Business Wire
Embarcadero Technologies, Inc. (NASDAQ: EMBT) today announced that
a NASDAQ Listing Qualifications Panel (the �Panel�) has granted an
extension of the previously-disclosed deadline to file its
Quarterly Report on Form 10-Q for the quarter ended September 30,
2006 and its Annual Report on Form 10-K for the year ended December
31, 2006 (the �Reports�). As previously announced, the Panel had
required that Embarcadero file the Reports by April 18, 2007 as a
condition to continued listing on the NASDAQ Global Select Market.
Embarcadero requested, and the Panel has granted, an extension of
this deadline to May 10, 2007. There can be no assurance that
Embarcadero will be able to file the Reports by May 10, 2007. In
the event that Embarcadero is unable to file the Reports by such
date, its securities may be delisted. About Embarcadero
Technologies Embarcadero Technologies, Inc. (Nasdaq: EMBT) delivers
professional grade database tools that companies use to design,
develop and manage databases and the data they contain. More than
12,000 customers worldwide and over 90 of the Fortune 100 rely on
Embarcadero�s cross-platform tools to reduce complexity, improve
productivity and strengthen security. The Company�s flagship
database tools include: ER/Studio, DBArtisan, Rapid SQL and Change
Manager. Founded in 1993, Embarcadero Technologies is headquartered
in San Francisco with offices in Melbourne, Australia, Munich,
Germany and Maidenhead, United Kingdom. For more information, visit
www.embarcadero.com. Forward- Looking Statements The statements in
this press release that are not historical facts are
forward-looking statements that involve risks and uncertainties,
including risks associated with non-compliance with NASDAQ listing
requirements and the possible delisting of our securities, the
ability of the Special Committee to complete its review of the
Company�s historical stock option grant practices, any findings or
restatements resulting from such review and fluctuations in
quarterly results and other risks identified in the Company�s
periodic filings with the Securities and Exchange Commission
including, but not limited to, those appearing under the caption
�Risk Factors� in the Company�s most recent Quarterly Reports on
Form 10-Q and Annual Report on Form 10-K. Actual results, events,
and performance may differ materially. Readers are cautioned not to
place undue relevance on these forward-looking statements, which
speak only as of the date hereof. Except as required by law, the
Company does not intend to release publicly the result of any
revisions to these forward-looking statements that may be made to
reflect events or circumstances after the date hereof or to reflect
the occurrence of anticipated events. Embarcadero, the Embarcadero
Technologies logos and all other Embarcadero Technologies product
or service names are trademarks of Embarcadero Technologies, Inc.
All other trademarks are property of their respective owners.
Ember Therapeutics (CE) (USOTC:EMBT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Ember Therapeutics (CE) (USOTC:EMBT)
Historical Stock Chart
From Oct 2023 to Oct 2024